193 related articles for article (PubMed ID: 15655556)
1. A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells.
Barr MP; Byrne AM; Duffy AM; Condron CM; Devocelle M; Harriott P; Bouchier-Hayes DJ; Harmey JH
Br J Cancer; 2005 Jan; 92(2):328-33. PubMed ID: 15655556
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling.
Jia H; Bagherzadeh A; Hartzoulakis B; Jarvis A; Löhr M; Shaikh S; Aqil R; Cheng L; Tickner M; Esposito D; Harris R; Driscoll PC; Selwood DL; Zachary IC
J Biol Chem; 2006 May; 281(19):13493-13502. PubMed ID: 16513643
[TBL] [Abstract][Full Text] [Related]
3. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor regulates stanniocalcin-1 expression via neuropilin-1-dependent regulation of KDR and synergism with fibroblast growth factor-2.
Holmes DI; Zachary IC
Cell Signal; 2008 Mar; 20(3):569-79. PubMed ID: 18164591
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia.
Barr MP; Bouchier-Hayes DJ; Harmey JJ
Int J Oncol; 2008 Jan; 32(1):41-8. PubMed ID: 18097541
[TBL] [Abstract][Full Text] [Related]
6. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
8. Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production.
Cheng L; Jia H; Löhr M; Bagherzadeh A; Holmes DI; Selwood D; Zachary I
J Biol Chem; 2004 Jul; 279(29):30654-61. PubMed ID: 15126502
[TBL] [Abstract][Full Text] [Related]
9. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines.
Lantuéjoul S; Constantin B; Drabkin H; Brambilla C; Roche J; Brambilla E
J Pathol; 2003 Jul; 200(3):336-47. PubMed ID: 12845630
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
Barr MP; Gray SG; Gately K; Hams E; Fallon PG; Davies AM; Richard DJ; Pidgeon GP; O'Byrne KJ
Mol Cancer; 2015 Feb; 14():45. PubMed ID: 25889301
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.
Bachelder RE; Crago A; Chung J; Wendt MA; Shaw LM; Robinson G; Mercurio AM
Cancer Res; 2001 Aug; 61(15):5736-40. PubMed ID: 11479209
[TBL] [Abstract][Full Text] [Related]
12. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
13. Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor.
von Wronski MA; Raju N; Pillai R; Bogdan NJ; Marinelli ER; Nanjappan P; Ramalingam K; Arunachalam T; Eaton S; Linder KE; Yan F; Pochon S; Tweedle MF; Nunn AD
J Biol Chem; 2006 Mar; 281(9):5702-10. PubMed ID: 16371354
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.
Castro-Rivera E; Ran S; Thorpe P; Minna JD
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11432-7. PubMed ID: 15273288
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor.
Shraga-Heled N; Kessler O; Prahst C; Kroll J; Augustin H; Neufeld G
FASEB J; 2007 Mar; 21(3):915-26. PubMed ID: 17185751
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity.
Ottino P; Finley J; Rojo E; Ottlecz A; Lambrou GN; Bazan HE; Bazan NG
Mol Vis; 2004 May; 10():341-50. PubMed ID: 15162095
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms.
Chakraborty G; Jain S; Kundu GC
Cancer Res; 2008 Jan; 68(1):152-61. PubMed ID: 18172307
[TBL] [Abstract][Full Text] [Related]
18. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected].
Gluzman-Poltorak Z; Cohen T; Herzog Y; Neufeld G
J Biol Chem; 2000 Jun; 275(24):18040-5. PubMed ID: 10748121
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
Soker S; Takashima S; Miao HQ; Neufeld G; Klagsbrun M
Cell; 1998 Mar; 92(6):735-45. PubMed ID: 9529250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
